Article: THE TICKER

BioChem AIDS Drug Outsells AZT MONTREAL - BioChem Pharma Inc. said Wednesday that U.S. sales of its new AIDS drug 3TC are outpacing those of Glaxo Wellcome's well-known AZT. BioChem Pharma Chief Executive Francesco Bellini told the Montreal-based biopharmaceutical company's annual meeting that U.S. sales of 3TC, sold as Epivir in the United States, had bypassed sales of AZT, which is sold under the brand name Retrovir. Bellini said 3TC sales in the United States were $40 million in the first quarter. German Economy Falters for 2nd Qtr. WIESBADEN - Germany's economy contracted for the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!